Last Updated: July 5, 2026

MOMETASONE Drug Patent Profile

Name: MOMETASONE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Mometasone patents expire, and when can generic versions of Mometasone launch?

Mometasone is a drug marketed by Chartwell Molecular, Cosette Pharms Nc, Fougera Pharms, Glenmark Pharms, Sun Pharma Canada, Cosette, Encube, Glenmark Pharms Ltd, Padagis Israel, Padagis Us, Torrent, Amneal, Amneal Pharms, Apotex, Aurobindo Pharma, and Naspress. and is included in twenty-five NDAs.

The generic ingredient in MOMETASONE is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Mometasone

A generic version of MOMETASONE was approved as mometasone furoate by PADAGIS US on March 18^th, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for MOMETASONE?
What are the global sales for MOMETASONE?
What is Average Wholesale Price for MOMETASONE?

Summary for MOMETASONE

US Patents:	0
Applicants:	16
NDAs:	25
Drug Prices:	Drug price information for MOMETASONE
Drug Sales Revenues:	Drug sales revenues for MOMETASONE
DailyMed Link:	MOMETASONE at DailyMed

Drug patent expirations by year for MOMETASONE

US Patents and Regulatory Information for MOMETASONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecular	MOMETASONE FUROATE	mometasone furoate	CREAM;TOPICAL	076591-001	Apr 18, 2007		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Torrent	MOMETASONE FUROATE	mometasone furoate	OINTMENT;TOPICAL	207899-001	Jul 13, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma	MOMETASONE FUROATE	mometasone furoate	SPRAY, METERED;NASAL	217498-001	Nov 22, 2024		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for MOMETASONE

Generic name for mometasone?
Mometasone nasal spray cost?
Mometasone furoate inhaler?
Mometasone non prescription cost?
Mometasone cream for baby?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.